SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Blackstone to Pay $750 Million to Fund J&J Drug Development

Blackstone will pay $750 million to fund Phase 3 development of OLN324.

JNJ

Story updates

01:06:11 PM UTC
SquawkNews
Johnson & Johnson: Blackstone to Pay $750 Million Over Multiple Years to Fully Fund Phase 3 Development of OLN324 >JNJ

Related stories